294 results on '"Harrison, Beth"'
Search Results
2. Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer
3. ASO Visual Abstract: Defining the Biology of Estrogen Receptor-Low Positive Breast Cancer
4. Kentucky Straight (review)
5. Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS
6. Invasive lobular carcinoma with extracellular mucin (ILCEM): clinicopathologic and molecular characterization of a rare entity
7. Columnar Cell Lesions and Flat Epithelial Atypia
8. Adenosis, Sclerosing Lesions, Microglandular Adenosis, and Mucocele-Like Lesions
9. Clinicogenomic characterization of inflammatory breast cancer
10. MRI Changes in Breast Skin Following Preoperative Therapy for Patients with Inflammatory Breast Cancer
11. Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations
12. Lobular neoplasia detected at MRI-guided biopsy: imaging findings and outcomes
13. ASO Visual Abstract: The Presence of Non-classic LCIS is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS
14. Detection of ERBB2 amplification in uterine serous carcinoma by next-generation sequencing: an approach highly concordant with standard assays
15. Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer
16. Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations
17. Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
18. Diagnostic Management of Papillomas, Radial Scars, and Flat Epithelial Atypia: Core Biopsy Alone Versus Core Biopsy Plus Excision
19. Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ
20. List of Contributors
21. Nonneoplastic Lesions of the Cervix
22. An Update of Mucinous Lesions of the Breast
23. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ
24. Copy Number Variation in Inflammatory Breast Cancer
25. Adenosis, Sclerosing Lesions, Microglandular Adenosis, and Mucocele-Like Lesions
26. Immunotherapy in acute myeloid leukaemia : development of methods for the use of dendritic cells as antigen presenting cells
27. Pan-TRK Immunohistochemistry: A Useful Diagnostic Adjunct For Secretory Carcinoma of the Breast
28. Nipple-Invasive Primary Carcinomas: Clinical, Imaging, and Pathologic Features of Breast Carcinomas Originating in the Nipple
29. Abstract P4-07-14: Long-term Outcomes After 1 or 2-3 Lines of Neoadjuvant Therapy in Stage III Inflammatory Breast Cancer
30. Zora Neale Hurston and Mary Austin: A Case Study in Ethnography, Literary Modernism, and Contemporary Ethnic Fiction
31. Contributing Authors
32. TRPS1 expression is sensitive and specific for primary extramammary Paget disease.
33. HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications
34. Familial Cancer Syndrome
35. Update on sentinel node pathology in breast cancer
36. YWHAE Rearrangement in a Purely Conventional Low-grade Endometrial Stromal Sarcoma that Transformed Over Time to High-grade Sarcoma: Importance of Molecular Testing
37. Glandular Pseudoneoplasms of the Uterine Cervix
38. Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer.
39. Detection of physiological deterioration by the SNAP40 wearable device compared to standard monitoring devices in the emergency department: the SNAP40-ED study
40. Is there a role for the oncotype DX breast recurrence score genomic assay in estrogen receptor-low positive breast cancer?
41. sj-docx-1-tam-10.1177_17588359221113269 – Supplemental material for Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer
42. Abstract P2-12-18: A phase 2 study of neoadjuvant systemic therapy with eribulin followed by doxorubicin and cyclophosphamide for HER2-negative inflammatory breast cancer
43. Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer
44. 7 - Nonneoplastic Lesions of the Cervix
45. Ellen Glasgow's Revision of the Southern Pastoral
46. Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer
47. Abstract PS14-21: Refining loco-regional therapy for inflammatory breast cancer protocol in progress
48. Abstract PS14-09: The impact of non-classic LCIS on the natural history of DCIS
49. Abstract PS10-34: Clinical outcomes inde novometastatic HER2-positive inflammatory breast cancer
50. Quality Assurance in Breast Pathology: Lessons Learned From a Review of Amended Reports
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.